Literature DB >> 33585203

Corrigendum: CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma.

Yue Song1,2,3, Wei Song4, Zhaoming Li1,3, Wenting Song1,2,3, Yibo Wen2, Jiwei Li1,3, Qingxin Xia4, Mingzhi Zhang1,3.   

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.00488.].
Copyright © 2020 Song, Song, Li, Song, Wen, Li, Xia and Zhang.

Entities:  

Keywords:  APC/C; CDC27; PD-L1; T-cell lymphoblastic lymphoma; cell cycle

Year:  2021        PMID: 33585203      PMCID: PMC7875015          DOI: 10.3389/fonc.2020.583698

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  1 in total

1.  Prognostic and clinical significance of subcellular CDC27 for patients with rectal adenocarcinoma treated with adjuvant chemotherapy.

Authors:  Chia-Lin Chang; Kevin Chih-Yang Huang; Tsung-Wei Chen; William Tzu-Liang Chen; Hsuan-Hua Huang; Ya-Ling Liu; Chia-Hui Kuo; K S Clifford Chao; Tao-Wei Ke; Shu-Fen Chiang
Journal:  Oncol Lett       Date:  2022-05-31       Impact factor: 3.111

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.